C. Baldini

发表

Ultra-High Frequency Ultrasound, A Promising Diagnostic Technique: Review of the Literature and Single-Center Experience

D. Caramella, M. Romanelli, R. Izzetti, 2020, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review.

A. Vissink, E. Theander, V. Devauchelle-Pensec, 2016, Rheumatology.

Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases.

D. Caramella, S. Bombardieri, C. Baldini, 2015, Rheumatology.

Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers.

S. Bombardieri, W. Bencivelli, R. Caporali, 2012, Clinical and experimental rheumatology.

Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren’s syndrome

D. Caramella, S. Bombardieri, C. Baldini, 2015, Arthritis Research & Therapy.

One year in review 2015: Sjögren's syndrome.

C. Baldini, N. Luciano, E. Bartoloni, 2015, Clinical and experimental rheumatology.

Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

S. Bombardieri, M. Isola, R. Priori, 2014, Journal of autoimmunity.

Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study

S. Bombardieri, M. Isola, R. Priori, 2015, Scandinavian journal of rheumatology.

Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.

S. Bombardieri, R. Priori, G. Valesini, 2015, Autoimmunity reviews.

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unm

Y. Shoenfeld, J. Pers, P. Sarzi-Puttini, 2017, Autoimmunity reviews.

Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue

S. Bombardieri, R. Priori, G. Valesini, 2017, The Journal of Rheumatology.

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development

D. Fotiadis, P. Voulgari, E. Zampeli, 2020, Frontiers in Immunology.

Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.

A. Vissink, D. Isenberg, J. Sánchez-Guerrero, 2021, Clinical and experimental rheumatology.

One year in review 2018: Sjögren's syndrome.

F. Ferro, C. Baldini, E. Bartoloni, 2018, Clinical and experimental rheumatology.

Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia

C. Baldini, L. Quartuccio, S. De Vita, 2007, Annals of the rheumatic diseases.

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

S. Bombardieri, R. Priori, G. Valesini, 2015, Lupus.

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2018, Clinical and experimental rheumatology.

Imaging in primary Sjögren's syndrome: the 'obsolete and the new'.

A. Vukicevic, N. Filipovic, F. Ferro, 2018, Clinical and experimental rheumatology.

SAT0190 LYMPHOMA IN PRIMARY SJÖGREN’S SYNDROME: A RETROSPECTIVE CLINICAL STUDY WITH PATIENTS FROM THE UPA (UDINE, PISA, ATHENS) GROUP

F. Ferro, C. Baldini, A. Tzioufas, 2019, SATURDAY, 15 JUNE 2019.

Fitness for purpose of routinely recorded health data to identify patients with complex diseases: The case of Sjögren's syndrome

John Paget, Chiara Seghieri, Sytske Wiegersma, 2020, Learning health systems.

Electronic Nose as a Novel Method for Diagnosing Cancer: A Systematic Review

C. Domenici, L. Billeci, A. Tonacci, 2020, Biosensors.

Anti-Sm and anti-RNP antibodies

S. Bombardieri, P. Migliorini, C. Baldini, 2005, Autoimmunity.

Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjögren's syndrome.

F. Ferro, C. Baldini, I. Puxeddu, 2019, Clinical and experimental rheumatology.

Seasonal Variability of Metallothioneins, Cytochrome P450, Bile Metabolites and Oxyradical Metabolism in the European Eel Anguilla anguilla L. (Anguillidae) and Striped Mullet Mugil cephalus L. (Mugilidae)

C. Baldini, F. Regoli, S. Gorbi, 2005, Archives of environmental contamination and toxicology.

The P2X7 receptor–NLRP3 inflammasome complex predicts the development of non‐Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single‐centre study

A. Solini, C. Baldini, V. Donati, 2017, Journal of internal medicine.

Biomarkers for Sjögren's syndrome.

S. Bombardieri, F. Ferro, C. Baldini, 2018, Biomarkers in medicine.

The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome

A. Solini, F. Ferro, C. Baldini, 2013, Journal of internal medicine.

One year in review 2016: Sjögren's syndrome.

F. Ferro, C. Baldini, C. Bruni, 2016, Clinical and experimental rheumatology.

Difference in clinical presentation between women and men in incident primary Sjögren’s syndrome

M. Kvarnström, C. Baldini, M. Wahren-Herlenius, 2017, Biology of Sex Differences.

From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials?

S. Bombardieri, A. Delle Sedie, C. Baldini, 2005, Clinical and experimental rheumatology.

How HCV has changed the approach to mixed cryoglobulinemia.

S. Bombardieri, A. Della Rossa, C. Baldini, 2009, Clinical and experimental rheumatology.

Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.

S. Bombardieri, P. Migliorini, C. Baldini, 2006, The Journal of rheumatology.

11 Sjögren ’ s Syndrome : The Proteomic Approaches

S. Bombardieri, A. Lucacchini, L. Giusti, 2017 .

Sjögren’s Syndrome: The Proteomic Approaches

S. Bombardieri, A. Lucacchini, L. Giusti, 2012 .

Ultrasound imaging for the rheumatologist. XXIII. Sonographic evaluation of hand joint involvement in primary Sjögren's syndrome.

A. Iagnocco, W. Grassi, S. Bombardieri, 2009, Clinical and experimental rheumatology.

Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus

A. Kühl, S. Bombardieri, S. Taddei, 2015, Arthritis Research & Therapy.

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status.

William J. Astle, Kenneth G. C. Smith, C. Wallace, 2019 .

The Association of Sjögren Syndrome and Autoimmune Thyroid Disorders

A. Antonelli, P. Fallahi, F. Ferro, 2018, Front. Endocrinol..

The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

P. Libby, R. de Caterina, C. Baldini, 2021, European heart journal.

Salivary Proteomics Markers for Preclinical Sjögren’s Syndrome: A Pilot Study

S. Rocchiccioli, G. Signore, F. Ferro, 2022, Biomolecules.

Undifferentiated connective tissue diseases (UCTD).

S. Bombardieri, C. Baldini, M. Mosca, 2006, Autoimmunity reviews.

Undifferentiated connective tissue diseases in 2004.

S. Bombardieri, C. Baldini, M. Mosca, 2004, Clinical and experimental rheumatology.

Celiac Disease Prevalence Is Increased in Primary Sjögren’s Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study

A. Gabrielli, V. Bini, A. Doria, 2019, Journal of clinical medicine.

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

William J. Astle, Georg Schett, Damjan Vukcevic, 2019, Nature Communications.

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

E. Bargagli, F. Cinetto, D. Roccatello, 2021, Arthritis & rheumatology.

Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology.

M. Cerinic, C. Vancheri, F. Ferro, 2019, Autoimmunity reviews.

A proposal of simple calculation (ERI calculator) to predict the early response to TNF-α blockers therapy in rheumatoid arthritis

S. Bombardieri, A. Della Rossa, A. Rossi, 2012, Rheumatology International.

A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies

C. Vancheri, F. Ferro, C. Baldini, 2022, Diagnostics.

Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?

S. Bombardieri, A. Lucacchini, L. Giusti, 2008, Autoimmunity reviews.

Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity

S. Bombardieri, F. Querci, C. Baldini, 2013, Clinical Rheumatology.

[Adherence to cervical cancer screening in an Italian SLE cohort].

S. Bombardieri, C. Baldini, M. Doveri, 2011, Reumatismo.

Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre.

D. Neglia, S. Bombardieri, A. Della Rossa, 2002, Rheumatology.

Chronic skin lichenification as unusual presentation of eosinophilic granulomatosis with polyangitis: case report and literature review.

F. Sbrana, B. Loggini, C. Baldini, 2016, Acta reumatologica portuguesa.

Clinical manifestations and treatment of Churg-Strauss syndrome.

S. Bombardieri, A. Della Rossa, C. Baldini, 2010, Rheumatic diseases clinics of North America.

[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome].

S. Bombardieri, A. Della Rossa, M. Bruzzone, 2011, Reumatismo.

Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature.

S. Bombardieri, A. Della Rossa, C. Baldini, 2012, Clinical and experimental rheumatology.

[Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre].

S. Bombardieri, A. Della Rossa, C. Baldini, 2011, Reumatismo.

LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus

S. Bombardieri, C. Baldini, M. Mosca, 2007, Expert opinion on pharmacotherapy.

One year in review 2017: systemic vasculitis.

C. Baldini, G. Lepri, R. Talarico, 2017, Clinical and experimental rheumatology.

One year in review 2018: systemic vasculitis.

C. Baldini, E. Cavallaro, G. Lepri, 2018, Clinical and experimental rheumatology.

Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: review of the literature and a cross-sectional prospective experience.

C. Baldini, P. Paggiaro, I. Dallan, 2018, The Journal of laryngology and otology.

Focus on audiologic impairment in eosinophilic granulomatosis with polyangiitis

C. Baldini, P. Paggiaro, I. Dallan, 2016, The Laryngoscope.

Systemic vasculitis: a critical digest of the recent literature.

S. Bombardieri, A. Della Rossa, C. Baldini, 2013, Clinical and experimental rheumatology.

The Journal of Rheumatology erythematosus.anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus Prevalence and clinico-serological correlations of anti-alpha-enolase,

P. Migliorini, C. Baldini, M. Mosca, 2006 .

Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2019, Rheumatology.

One year in review: systemic vasculitis.

F. Ferro, C. Baldini, E. Elefante, 2016, Clinical and experimental rheumatology.

THU0004 Patterns of Inflammation and Dysfunction of the Salivary Glands in Patients Newly Diagnosed with SjÖGren's Syndrome

S. Bombardieri, C. Baldini, M. Mosca, 2014 .

THU0188 Lymphoproliferative complications in the course of primary sjægren’s syndrome: Prevalence and common features in a large cohort of patients

S. Bombardieri, M. Isola, R. Priori, 2013 .

One year in review 2016: idiopathic inflammatory myopathies.

C. Baldini, E. Cioffi, S. Tenti, 2016, Clinical and experimental rheumatology.

Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren’s syndrome

A. Vissink, C. Shiboski, X. Mariette, 2020, Journal of internal medicine.

Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews

S. Bombardieri, P. Migliorini, L. Bazzichi, 2008, Clinical Rheumatology.

Characterization of a new regulatory CD4 + T cell subset in primary Sjo¨gren’s syndrome RHEUMATOLOGY

C. Riccardi, I. Nicoletti, C. Baldini, 2013 .

Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients.

D. Caramella, S. Bombardieri, A. Della Rossa, 2013, Autoimmunity reviews.

TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review

S. Bombardieri, A. Della Rossa, A. Delle Sedie, 2015, Modern rheumatology.

One year in review 2019: vasculitis.

F. Ferro, C. Baldini, E. Cavallaro, 2019, Clinical and experimental rheumatology.

Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

X. Mariette, E. Theander, S. Bombardieri, 2016, Expert review of clinical immunology.

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci strati ﬁ ed by ANCA status

William J. Astle, Kenneth G. C. Smith, C. Wallace, 2019 .

Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis.

S. Bombardieri, A. Della Rossa, F. Querci, 2013, Reumatismo.

One year in review 2015: idiopathic inflammatory myopathies.

C. Baldini, G. L. La Paglia, R. Neri, 2015, Clinical and experimental rheumatology.

Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature

M. Gelardi, C. Baldini, P. Paggiaro, 2018, International Archives of Allergy and Immunology.

Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome

A. Vissink, X. Mariette, Y. Shoenfeld, 2021, Drugs & Aging.

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.

J. Sánchez-Guerrero, X. Mariette, S. Bombardieri, 2019, Clinical and experimental rheumatology.

Classification criteria in Sjögren's syndrome.

S. Bombardieri, F. Ferro, C. Baldini, 2017, Annals of translational medicine.

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).

M. Suarez‐Almazor, X. Mariette, J. Gottenberg, 2019, Clinical and experimental rheumatology.

Imaging Ultrasound imaging for the rheumatologist XXIII . Sonographic evaluation of hand joint involvement in primary Sjögren ’ s syndrome

A. Iagnocco, W. Grassi, S. Bombardieri, 2006 .

Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?

D. Neglia, M. Lombardi, S. Bombardieri, 2005, Rheumatology.

Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis.

S. Bombardieri, A. Della Rossa, W. Bencivelli, 2013, Clinical and experimental rheumatology.

[Primary Sjogren's syndrome: clinical and serological feature of a single centre].

S. Bombardieri, C. Baldini, M. Sebastiani, 2011, Reumatismo.

Updates on Sjögren’s syndrome: from proteomics to protein biomarkers

S. Bombardieri, C. Baldini, A. Gallo, 2017, Expert review of proteomics.

Unusual concomitant small‐ and large‐fiber neuropathy related to hypereosinophilic syndrome

G. Siciliano, B. Loggini, V. Dini, 2021 .

Comorbidities (excluding lymphoma) in Sjögren's syndrome.

C. Baldini, J. Pego-Reigosa, Í. Rúa-Figueroa Fernández de Larrinoa, 2019, Rheumatology.

Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation.

M. Suarez‐Almazor, X. Mariette, C. Robert, 2021, European journal of cancer.

Introduction: History of Sjögren’s Syndrome

S. Bombardieri, C. Baldini, 2016 .

Vitamin D in “early” primary Sjögren’s syndrome: does it play a role in influencing disease phenotypes?

A. Delle Sedie, F. Ferro, C. Baldini, 2014, Rheumatology International.

The classification criteria for Sjögren syndrome: issues for their improvement from the study of a large Italian cohort of patients

S. Bombardieri, R. Priori, G. Valesini, 2014, Annals of the Rheumatic Diseases.

Outcome of Pregnancy in Italian Patients with Primary Sjögren Syndrome

S. Bombardieri, R. Priori, G. Valesini, 2013, The Journal of Rheumatology.

Connexin Expression in Human Minor Salivary Glands: An Immunohistochemical Microscopy Study

C. Baldini, F. Bianchi, V. Donati, 2022, Molecules.

Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.

A. Vissink, D. Isenberg, X. Mariette, 2021, Rheumatology.

Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.

V. Bini, R. Priori, F. Ferro, 2020, Clinical and experimental rheumatology.

Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.

A. Vissink, D. Isenberg, J. Gottenberg, 2020, Clinical and experimental rheumatology.

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma

A. Tappuni, R. Priori, S. Challacombe, 2020, Annals of the Rheumatic Diseases.

Childhood-onset of primary Sjogren syndromePhenotypic characterization at diagnosis of 158 children

A. Vissink, D. Isenberg, S. Bombardieri, 2020, medRxiv.

Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome

X. Mariette, J. Gottenberg, T. Dörner, 2019, RMD Open.

Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine

S. Bombardieri, S. Rocchiccioli, N. Ucciferri, 2019, Clinical Proteomics.

Sjögren’s syndrome: state of the art on clinical practice guidelines

Matthias Schneider, X. Mariette, S. Bombardieri, 2018, RMD Open.

Advances in salivary gland ultrasonography in primary Sjögren's syndrome.

S. Bombardieri, F. Ferro, C. Baldini, 2018, Clinical and experimental rheumatology.

One year in review 2017: primary Sjögren's syndrome.

F. Ferro, C. Baldini, E. Bartoloni-Bocci, 2017, Clinical and experimental rheumatology.

Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome.

S. Bombardieri, R. Priori, G. Valesini, 2017, Clinical and experimental rheumatology.

In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience

M. Nardi, S. Bombardieri, F. Ferro, 2015, Modern rheumatology.

Pain in Sjögren's syndrome.

C. Giacomelli, L. Bazzichi, C. Baldini, 2014, Reumatismo.

Concise Report

S. Bombardieri, R. Priori, G. Valesini, 2022 .

Concise report Primary Sjo¨gren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients

S. Bombardieri, R. Priori, G. Valesini, 2014 .

both SS diagnosis and classification.

S. Bombardieri, R. Priori, G. Valesini, 2014 .

Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren’s Syndrome

I. Alevizos, C. Giacomelli, C. Baldini, 2013, Journal of genetic syndromes & gene therapy.

Classification criteria for Sjogren's syndrome: a critical review.

S. Bombardieri, C. Baldini, A. Tzioufas, 2012, Journal of autoimmunity.

Mucocutaneous Manifestations of Sjogren's Syndrome

S. Bombardieri, C. Baldini, 2006 .

Bruton’s Tyrosine Kinase (BTK) Inhibitors: New Possible Good Candi- dates Against COVID-19

C. Baldini, F. Morabito, I. Puxeddu, 2020 .

Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?

A. Della Rossa, C. Baldini, M. Mosca, 2013, Clinical and experimental rheumatology.

Vasculite di Churg-Strauss e sindrome ipereosinofila idiopatica: ruolo della biologia molecolare nella diagnosi differenziale delle sindromi ipereosinofile* Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl sy

S. Bombardieri, M. Bruzzone, C. Baldini, 2008 .

Mixed cryoglobulinemia and hepatitis C virus association: ten years later.

S. Bombardieri, A. Della Rossa, C. Baldini, 2001, The Israel Medical Association journal : IMAJ.

Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review

M. Egidi, A. Cupisti, F. Ferro, 2020, CEN Case Reports.

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

R. B. Henderson, P. Tak, X. Mariette, 2022, JCI insight.

Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.

S. Bombardieri, A. Della Rossa, F. Ferro, 2013, Clinical and experimental rheumatology.

Treatment of chronic hepatitis C infection with cryoglobulinemia

S. Bombardieri, A. Della Rossa, C. Baldini, 2002, Current opinion in rheumatology.

Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?

S. Bombardieri, F. Ciregia, A. Delle Sedie, 2010, Proteomics. Clinical applications.

Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement?

S. Bombardieri, F. Ciregia, G. Giannaccini, 2008, The Journal of rheumatology.

Highlights of the 14th International Symposium in Sjögren's Syndrome.

I. Alevizos, C. Baldini, A. Baer, 2018, Clinical and experimental rheumatology.

Highlights of the 14 th International Symposium on Sjögren ’ s Syndrome

I. Alevizos, C. Baldini, A. Baer, 2018 .

Sjögren Syndrome Disease Activity Index ( ESSDAI ) and the Clinical ESSDAI ( ClinESSDAI

S. Bombardieri, R. Priori, G. Valesini, 2017 .

SAT0207 Correlation of clinical, serologic and histologic findings in a large cohort of primary sjögren’s syndrome patients: A multicentric cross-sectional study

S. Bombardieri, R. Priori, G. Valesini, 2013 .

Mortality in giant cell arteritis: analysis of a monocentric cohort of biopsy-proven patients.

S. Bombardieri, C. Baldini, A. D'ascanio, 2013, Clinical and experimental rheumatology.

Total area of inflammatory infiltrate and percentage of inflammatory infiltrate identify different clinical-serological subsets of primary Sjögren's syndrome better than traditional histopathological parameters.

R. Izzetti, F. Ferro, C. Baldini, 2020, Clinical and experimental rheumatology.

Prognosis and Disease Activity

S. Bombardieri, C. Baldini, A. D'ascanio, 2014 .

Rate of serious infections in Behçet’s disease patients receiving biologic therapies: a prospective observational study

S. Bombardieri, L. Bazzichi, C. Baldini, 2013, Clinical Rheumatology.

Future prospects for salivary proteomics in rheumatology: the example of eosinophil granulomatosis with polyangiitis.

A. Della Rossa, C. Baldini, M. Mosca, 2012, Clinical and experimental rheumatology.

Behçet's disease: features of neurological involvement in a dedicated centre in Italy.

S. Bombardieri, C. Baldini, A. D'ascanio, 2012, Clinical and experimental rheumatology.

Sjögren’s Syndrome: The Clinical Spectrum of Male Patients

D. Fotiadis, P. Voulgari, E. Zampeli, 2020, Journal of clinical medicine.

Salivary Gland Ultrasonography in Sjögren's Syndrome: Clinical Usefulness and Future Perspectives.

S. Bombardieri, C. Baldini, M. Mosca, 2016, The Israel Medical Association journal : IMAJ.

A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren's syndrome.

A. Tappuni, C. Baldini, C. Pitzalis, 2018, Clinical and experimental rheumatology.

Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjögren's syndrome (pSS) clinical trials?

M. Nardi, S. Bombardieri, F. Ferro, 2012, Clinical and experimental rheumatology.

Ultra-high frequency ultrasonography of labial glands is a highly sensitive tool for the diagnosis of Sjögren's syndrome: a preliminary study.

D. Caramella, R. Izzetti, M. Gabriele, 2020, Clinical and experimental rheumatology.

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

M. Humbert, P. Merkel, E. Bel, 2015, European journal of internal medicine.

Ezrin Is a Novel Protein Partner of Aquaporin-5 in Human Salivary Glands and Shows Altered Expression and Cellular Localization in Sjögren’s Syndrome

K. Schey, Zhen Wang, C. Delporte, 2021, International journal of molecular sciences.

Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients

K. Schey, Zhen Wang, C. Delporte, 2021, Cells.

Sjögren syndrome

R. Jonsson, X. Mariette, E. Theander, 2016, Nature Reviews Disease Primers.

Major Salivary Gland Ultrasonography in the Diagnosis of Sjögren's Syndrome: A Place in the Diagnostic Criteria?

C. Baldini, M. Jonsson, 2016, Rheumatic diseases clinics of North America.

Mikulicz's disease: a long-term follow-up case report.

A. Delle Sedie, C. Baldini, M. Mosca, 2012, Clinical and experimental rheumatology.

SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients

A. Vissink, F. Giardina, D. Isenberg, 2020, Rheumatology.

Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.

S. Bombardieri, P. Pérez, I. Alevizos, 2012, Clinical and experimental rheumatology.

Salivary gland ultrasound abnormalities in primary Sjögren’s syndrome: consensual US-SG core items definition and reliability

John Rout, Alain Saraux, Arjan Vissink, 2017, RMD Open.

The use of digital image analysis in the histological assessment of Sjögren's syndrome salivary glands improves inter-rater agreement and facilitates multi-centre data harmonisation.

A. Tappuni, C. Baldini, V. Donati, 2020, Clinical and experimental rheumatology.

Proteomic diagnosis of Sjögren’s syndrome

S. Bombardieri, A. Lucacchini, L. Giusti, 2007, Expert review of proteomics.

A Clinical Prediction Rule for Lymphoma Development in Primary Sjögren’s Syndrome

S. Bombardieri, F. Ferro, C. Baldini, 2012, The Journal of Rheumatology.

Proteome analysis of whole saliva: A new tool for rheumatic diseases – the example of Sjögren's syndrome

Chiara Baldini, Ilaria Tonazzini, I. Tonazzini, 2007, Proteomics.

Characterization of Extracellular Vesicle Cargo in Sjögren’s Syndrome through a SWATH-MS Proteomics Approach

S. Rocchiccioli, G. Signore, F. Ferro, 2021, International journal of molecular sciences.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2016, Annals of the rheumatic diseases.

MicroRNA-mediated Regulation of Mucin-type O-glycosylation Pathway: A Putative Mechanism of Salivary Gland Dysfunction in Sjögren Syndrome

S. Bombardieri, I. Alevizos, F. Ferro, 2019, The Journal of Rheumatology.

Ultra-high frequency ultrasound (UHFUS) applications in Sjogren syndrome: narrative review and current concepts.

D. Caramella, R. Izzetti, M. Gabriele, 2020, Gland surgery.

Current Concepts on Classification Criteria and Disease Status Indexes in Sjögren’s Syndrome

S. Bombardieri, C. Vitali, C. Baldini, 2011 .

Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis

William J. Astle, Kenneth G. C. Smith, C. Wallace, 2018, bioRxiv.

One year in review 2020: pathogenesis of primary Sjögren's syndrome.

F. Ferro, C. Baldini, A. Tzioufas, 2020, Clinical and experimental rheumatology.

One year in review 2019: Sjögren's syndrome.

F. Ferro, C. Baldini, E. Bartoloni, 2019, Clinical and experimental rheumatology.

The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia

D. Liberati, C. Baldini, A. Di Paolo, 2019, Front. Oncol..

The CoV-2 outbreak: how hematologists could help to fight Covid-19

L. Baglietto, E. Lucenteforte, F. Ferro, 2020, Pharmacological Research.

Detection of potential markers of primary fibromyalgia syndrome in human saliva

S. Bombardieri, F. Ciregia, G. Giannaccini, 2009, Proteomics. Clinical applications.

AB0925 Liver Involvement in Adult Onset Still's Disease: Retrospective Analysis of 18 Cases

S. Bombardieri, A. Della Rossa, F. Ferro, 2014 .

Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes

S. Bombardieri, F. Ciregia, G. Giannaccini, 2011, Arthritis research & therapy.

Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis.

Chiara Baldini, S. Bombardieri, F. Ciregia, 2007, The Journal of rheumatology.

Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review

C. Vancheri, F. Ferro, C. Baldini, 2023, Frontiers in Medicine.

Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.

C. Riccardi, I. Nicoletti, C. Baldini, 2013, Rheumatology.

Skin involvement and outcome measures in systemic autoimmune diseases.

M. Dalakas, S. Bombardieri, P. Sarzi-Puttini, 2006, Clinical and experimental rheumatology.

Systemic vasculitis and the lung

C. Baldini, M. Mosca, R. Talarico, 2017, Current opinion in rheumatology.

Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature

A. Della Rossa, C. Baldini, A. D'ascanio, 2017, Rheumatology International.

Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham’s Chorea: A Multicenter Prospective Study

R. Consolini, A. Vignoli, T. Foiadelli, 2022, International journal of environmental research and public health.

THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)

M. Suarez‐Almazor, X. Mariette, J. Gottenberg, 2019, Poster Presentations.

Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults.

F. Guaraldi, G. Beccuti, S. Grottoli, 2012, European journal of endocrinology.

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

S. Bombardieri, V. Bini, G. Schillaci, 2015, Journal of internal medicine.

The diagnosis and classification of mixed connective tissue disease.

S. Bombardieri, C. Baldini, L. Carli, 2014, Journal of autoimmunity.

AB0627 Evaluation of internal consistency, feasibility, and reliability of the Italian version of ANCA-associated vasculitis patient-reported outcome (AAV-PRO_ita) questionnaire: preliminary results from a multicenter study on a large cohort of Italian patients

S. Sartorelli, L. Dagna, R. Caporali, 2022, Annals of the Rheumatic Diseases.

One year in review 2021: systemic vasculitis.

F. Ferro, C. Baldini, R. Talarico, 2021, Clinical and experimental rheumatology.

[Analysis of the evolution to defined connective tissue diseases of patients with "early unidifferentiated connective tissue diseases (UCTD)"].

S. Bombardieri, A. Della Rossa, C. Baldini, 2011, Reumatismo.

A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.

D. Fotiadis, T. Exarchos, P. Voulgari, 2021, Journal of autoimmunity.

Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report

S. Bombardieri, F. Ciregia, A. Lucacchini, 2011, Journal of Translational Medicine.

Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.

E. Grossi, S. Bombardieri, F. Ferro, 2018, Clinical and experimental rheumatology.

Myositis in primary Sjögren's syndrome: data from a multicentre cohort.

S. Bombardieri, R. Priori, G. Valesini, 2015, Clinical and experimental rheumatology.

Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2

L. Baglietto, C. Baldini, A. Di Paolo, 2020, Frontiers in Oncology.

FRI0419 Big Data Sjogren Project (Eular-SS Task Force International Network): Systemic Involvement at Diagnosis Evaluated by the Essdai in 3314 Patients with Primary Sjögren Syndrome

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2015 .

Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study.

D. Fotiadis, C. Baldini, A. Tzioufas, 2023, Joint bone spine.

Cystatin S—a candidate biomarker for severity of submandibular gland involvement in Sjögren’s syndrome

C. Baldini, M. Mosca, N. Luciano, 2017, Rheumatology.

Addressing the clinical unmet needs in primary Sjögren’s Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts

D. Fotiadis, R. Jonsson, M. Tsiknakis, 2022, Computational and structural biotechnology journal.

The economic impact of gout: a systematic literature review.

Giuseppe Turchetti, Leopoldo Trieste, Ilaria Palla, 2012, Clinical and experimental rheumatology.

Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies

F. Ferro, C. Baldini, G. Sambataro, 2023, Journal of clinical medicine.

Emerging trends in Sjögren's syndrome: basic and translational research.

S. Bombardieri, I. Alevizos, C. Baldini, 2012, Clinical and experimental rheumatology.

Sjögren's syndrome: one year in review 2022.

F. Ferro, C. Baldini, V. Manfrè, 2022, Clinical and experimental rheumatology.

Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.

F. Ferro, C. Baldini, C. Romei, 2022, Clinical and experimental rheumatology.

POS1242 BARICITINIB AND PULSE STEROIDS COMBINED TREATMENT IN SEVERE COVID-19 PNEUMONIA: PRELIMINARY DATA FROM A RHEUMATOLOGIC EXPERIENCE IN INTENSIVE CARE UNIT

F. Ferro, C. Baldini, M. Mosca, 2022, Annals of the Rheumatic Diseases.

AB0510 LUNG ULTRASOUND OF PLEURAL IRREGULARITIES IN SUB-CLINICAL PRIMARY SJÖGREN’S SYNDROME-LUNG INVOLVEMENT: A SINGLE CENTRE EXPERIENCE

F. Ferro, C. Baldini, M. Mosca, 2019, Abstracts Accepted for Publication.

Analysis of the evolution of UCTD to defined CTD after a long term follow-up.

S. Bombardieri, A. Della Rossa, C. Baldini, 2013, Clinical and experimental rheumatology.

Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients.

S. Bombardieri, R. Priori, G. Valesini, 2007, Arthritis and rheumatism.

THU0308 Extensive analysis of T cell receptor gamma (TCRG) gene rearrangements reveals a similar repertoire in eosinophilic granulomatosis with polyangiitis (EGPA) and in hypereosinophilic syndrome (HES)

N. Pisanti, F. Ferro, C. Baldini, 2017 .

Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome

R. Priori, F. Ferro, C. Baldini, 2021, Frontiers in Immunology.

Variation in primary Sjögren's syndrome care among European countries.

T. Exarchos, F. Ferro, C. Baldini, 2019, Clinical and experimental rheumatology.

Ultra-high frequency ultrasonography (UHFUS)-guided minor salivary gland biopsy: a promising procedure to optimize labial salivary gland biopsy in Sjögren's Syndrome.

D. Caramella, R. Izzetti, T. Oranges, 2021, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Asthma Control and Airway Inflammation in Patients with Eosinophilic Granulomatosis with Polyangiitis.

S. Bombardieri, C. Baldini, P. Pepe, 2016, The journal of allergy and clinical immunology. In practice.

Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts.

R. Priori, G. Valesini, F. Ferro, 2020, Clinical and experimental rheumatology.

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease.

D. Fotiadis, P. Voulgari, E. Zampeli, 2020, Seminars in arthritis and rheumatism.

COVID-19: the new challenge for rheumatologists.

S. Bombardieri, F. Ferro, C. Baldini, 2020, Clinical and experimental rheumatology.

Skin Blood Flow in Systemic Sclerosis

S. Bombardieri, C. Baldini, M. Mosca, 2015 .

THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY)

M. Suarez‐Almazor, X. Mariette, J. Gottenberg, 2019, Poster Presentations.

Alterations of the oral cavity in charge to users of home care services: a survey of prevalence

C. Baldini, E. Rinaldini, D. Calamassi, 2012 .

Predicting lymphoma in Sjögren’s syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording

D. Fotiadis, R. Fanin, D. Rontogianni, 2022, Rheumatology.

SAT0683 A north-south worldwide gradient in systemic activity of primary sjÖgren syndrome: increased severe disease in patients from southern countries

D. Isenberg, J. Gottenberg, V. Devauchelle-Pensec, 2018, Saturday, 16 JUNE 2018.

Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies.

A. Vissink, D. Isenberg, X. Mariette, 2022, Rheumatology.

COVID-19: the new challenge for rheumatologists. One year later.

S. Bombardieri, P. Migliorini, F. Ferro, 2021, Clinical and experimental rheumatology.

Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario?

E. Grossi, S. Bombardieri, F. Ferro, 2019, Clinical and experimental rheumatology.

Skin Manifestations and Cryoglobulinemia

S. Bombardieri, C. Baldini, R. Talarico, 2014 .

Interplay of anti‐SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren’s syndrome

V. Bini, R. Priori, C. Baldini, 2020, Journal of Internal Medicine.

Overcoming the Barriers That Obscure the Interlinking and Analysis of Clinical Data Through Harmonization and Incremental Learning

Dimitrios I. Fotiadis, Themis P. Exarchos, Vasileios C. Pezoulas, 2020, IEEE Open Journal of Engineering in Medicine and Biology.

Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

A. Vissink, X. Mariette, S. Bombardieri, 2023, eClinicalMedicine.

FRI0260 Ultrasound study of pleural profile and chest high-resolution computed tomography (HRCT): diagnostic role in primary sjÖgren's syndrome-induced lung involvement

F. Ferro, C. Baldini, M. Mosca, 2017 .

Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine

S. Bombardieri, S. Rocchiccioli, N. Ucciferri, 2019, Clinical proteomics.

Difference in clinical presentation between women and men in incident primary Sjögren’s syndrome

M. Kvarnström, C. Baldini, M. Wahren-Herlenius, 2017, Biology of Sex Differences.

Systemic vasculitis: one year in review 2022.

F. Ferro, C. Baldini, R. Talarico, 2022, Clinical and experimental rheumatology.

UHFUS: A Valuable Tool in Evaluating Exocrine Gland Abnormalities in Sjögren’s Disease

R. Izzetti, G. Aringhieri, F. Ferro, 2023, Diagnostics.

POS1461 ADVANTAGES OF DOPPLER IN LABIAL SALIVARY GLAND ULTRA-HIGH FREQUENCY ULTRASOUND: CORRELATIONS WITH HISTOLOGICAL INFLAMMATION, pSS DIAGNOSIS, DISEASE ACTIVITY, AND PROGNOSIS

V. Donati, R. Izzetti, F. Ferro, 2023, Annals of the Rheumatic Diseases.

Correspondence between minor salivary glands ultra-high frequency ultrasonography and histology: a case report of severe/atypical lymphoid infiltrate in Sjögren's syndrome.

R. Izzetti, F. Ferro, C. Baldini, 2022, Clinical and experimental rheumatology.

One year in review 2021: Sjögren's syndrome

F. Ferro, C. Baldini, E. Bartoloni, 2021, Clinical and Experimental Rheumatology.

Ultra-High-Frequency Ultrasonography of Labial Glands in Pediatric Sjögren’s Disease: A Preliminary Study

R. Izzetti, T. Oranges, V. Dini, 2023, Diagnostics.

One year in review 2020: vasculitis.

F. Ferro, C. Baldini, R. Talarico, 2020, Clinical and experimental rheumatology.

THU0259 ULTRASOUND OF MAJOR SALIVARY GLANDS IDENTIFIES PATIENTS WITH MORE COMPLEX SALIVARY GLAND HISTOPATHOLOGY BUT NOT MILDER LESIONS

S. Bombardieri, F. Ferro, C. Baldini, 2019, Poster Presentations.

Is Ultrasonography Of Salivary Gland a Validate Tool In Sjogren Syndrome? Study 1

A. Vissink, R. Jonsson, M. Carotti, 2013 .

Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?

C. Baldini, R. Giacomelli, O. Berardicurti, 2023, Autoimmunity reviews.

Combined seronegativity in Sjögren's syndrome.

D. Fotiadis, T. Exarchos, P. Voulgari, 2021, Clinical and Experimental Rheumatology.

Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.

S. Bombardieri, R. Priori, G. Valesini, 2014, Rheumatology.

THU0304 Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP): A Functional Salivary Biomarker for Primary SjöGren’s Syndrome?

S. Bombardieri, A. Solini, I. Alevizos, 2013 .

Development of de novo major involvement during follow-up in Behçet’s syndrome

S. Bombardieri, C. Baldini, A. D'ascanio, 2015, Clinical Rheumatology.

Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

X. Mariette, E. Theander, S. Bombardieri, 2016, Expert review of clinical immunology.

Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis.

S. Bombardieri, A. Della Rossa, W. Bencivelli, 2013, Clinical and experimental rheumatology.

URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN A MURINE MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS

S. Bombardieri, F. Querci, C. Baldini, 2022 .

Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.

B. Armağan, V. Fernandes Moça Trevisani, G. Nordmark, 2023, Clinical and experimental rheumatology.

TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME

S. Bombardieri, C. Baldini, P. Paggiaro, 2013 .

AB0618 A SNAPSHOT OF DISEASE ACTIVITY IN PATIENTS WITH BEHCET’S SYNDROME: PREDICTIVE FACTORS AND RELATIONSHIP WITH QUALITY OF LIFE

C. Baldini, M. Mosca, R. Talarico, 2019, Abstracts accepted for Publication.

Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters

C. Baldini, M. Infantino, R. Gerli, 2023, RMD Open.

Impact of gender and age at onset on Sjögren's syndrome presentation and outcome: state of the art.

F. Ferro, C. Baldini, E. Bartoloni, 2023, Clinical and experimental rheumatology.

Systemic vasculitis: one year in review 2023.

F. Ferro, C. Baldini, R. Talarico, 2023, Clinical and experimental rheumatology.